hemophagocyt
lymphohistiocytosi
hlh
character
activ
mononuclear
phagocyt
system
histiocyt
prolifer
hemophagocytosi
clinic
hlh
rare
potenti
fatal
hyperinflammatori
syndrom
typic
find
high
fever
hepatosplenomegali
cytopenia
hypertriglyceridemia
hyperferritinemia
hypofibrinogenemia
hemophagocytosi
bone
marrow
bm
organ
henter
et
al
diagnosi
hlh
adult
challeng
hlh
occur
mani
diseas
entiti
result
symptom
similar
diseas
also
etiolog
identifi
mani
patient
heterogen
etiolog
nonspecif
clinic
laboratori
find
hlh
often
lead
delay
diagnosi
misdiagnosi
thu
mortal
rate
result
diseas
quit
high
hlh
may
inherit
ie
primari
famili
gener
occur
infant
secondari
diseas
contrari
primari
hlh
secondari
hlh
shlh
occur
age
associ
wide
spectrum
underli
condit
park
et
al
infect
main
trigger
shlh
constitut
report
case
includ
viral
bacteri
fungal
parasit
infect
present
viral
infect
frequent
trigger
shlh
either
primari
infect
healthi
peopl
reactiv
infect
patient
immunosuppress
diseas
et
al
viral
infect
may
trigger
shlh
lymphocyt
activ
proinflammatori
cytokin
secret
countri
virus
common
infecti
agent
associ
shlh
follow
bacteria
parasit
fungi
tiab
et
al
dean
et
al
subtyp
shlh
confer
higher
mortal
rate
seen
primari
hlh
rouphael
et
al
thorough
investig
underli
etiolog
benefici
proper
diagnosi
time
treatment
diseas
shlh
varieti
prognos
rang
mild
natur
cours
shlh
rapidli
fatal
within
day
week
patient
clinic
manifest
diseas
cours
treatment
respons
affect
shlh
also
possibl
underli
condit
park
kim
et
al
formal
guidelin
evalu
patient
shlh
establish
fisman
although
mani
virus
viru
ebv
human
herp
viru
cytomegaloviru
cmv
influenza
viru
hepat
viru
parvoviru
identifi
trigger
shlh
fardet
et
al
henter
et
al
yilmaz
et
al
rouphael
talati
et
al
titz
et
al
demircioglu
et
al
mani
previou
studi
base
sporad
case
report
shlh
high
viral
dna
load
associ
poor
outcom
rouphael
talati
et
al
direct
molecular
virolog
assay
may
help
better
detect
potenti
diseas
although
diagnosi
consid
virus
associ
shlh
would
practic
current
order
elucid
relationship
viral
infect
incid
shlh
patient
shlh
select
studi
virus
frequent
epidem
local
area
measur
patient
serum
sampl
viral
etiolog
demograph
clinic
featur
outcom
shlh
patient
analyz
patient
fulfil
five
eight
criteria
shlh
fever
splenomegali
cytopenia
two
cell
type
absolut
neutrophil
count
anc
hemoglobin
level
gl
andor
platelet
count
hypertriglyceridemia
triglycerid
level
mmoll
hypofibrinogenemia
fibrinogen
fib
level
gl
hemophagocytosi
bm
shlh
typic
featur
activ
macrophag
engulf
leucocyt
erythrocyt
precursor
cell
platelet
hyperferritinemia
ferritin
level
elev
solubl
chain
iuml
low
absent
natur
killer
nk
cell
cytotox
patient
adult
famili
histori
hlh
laboratori
test
includ
complet
blood
count
cbc
blood
cell
morpholog
protein
crp
serum
igg
igm
iga
biochem
marker
includ
aspart
transaminas
ast
alanin
transaminas
alt
transpeptidas
ggt
lactat
dehydrogenas
ldh
alkalin
phosphatas
alp
fib
ferritin
triglycerid
cholesterol
order
distinguish
patient
infect
malign
diseas
bm
aspir
tumor
biomark
test
perform
patient
except
lymphoma
leukemia
solid
tumor
found
patient
patient
treat
accord
protocol
consist
initi
therapi
dexamethason
per
day
etoposid
twice
weekli
cyclosporin
follow
dexamethason
intraven
puls
henter
horn
et
al
identifi
viral
etiolog
shlh
virus
hyperendem
epidem
infect
local
area
measur
includ
ebv
influenza
viru
flu
flub
parainfluenza
viru
type
respiratori
syncyti
viru
rsv
adenoviru
adv
coronaviru
human
metapneumoviru
mpv
bocaviru
hbov
rhinoviru
hrv
human
papillomaviru
hpv
herp
simplex
parvoviru
human
immunodefici
viru
hiv
also
measur
virus
detect
use
quantit
polymeras
chain
reaction
plasma
sampl
dnarna
extract
polymeras
chain
reaction
accord
manufactur
instruct
qiagen
hilden
germani
dna
extract
serum
use
qiaamp
dna
blood
mini
kit
rna
extract
use
qiaamp
viral
rna
mini
kit
highli
purifi
dna
amplifi
use
pcr
kit
qiagen
includ
primer
dna
detect
pcr
use
qpcr
master
mix
ambion
carlsbad
ca
program
consist
one
cycl
min
follow
cycl
sec
sec
rna
detect
use
kit
ambion
carlsbad
program
consist
one
cycl
min
min
follow
cycl
sec
sec
order
confirm
examin
use
specif
primer
probe
reaction
perform
abi
system
appli
biosystem
primer
provid
center
diseas
control
prevent
guangdong
provinc
purifi
water
use
neg
control
viral
load
express
number
ebv
dna
copiesml
presenc
viral
load
support
diagnosi
shlh
primer
viru
detect
shlh
patient
viramia
primer
forward
revers
probe
fam
primer
forward
revers
probe
fam
mgb
mpv
primer
forward
revers
probe
fam
ebv
primer
forward
revers
probe
fam
order
exclud
infecti
factor
could
induc
shlh
pathogen
measur
includ
chlamydia
speci
rickettsia
speci
orientia
tsutsugamushi
campylobact
fusobacterium
mycoplasma
legionella
typhoid
brucella
lyme
diseas
enceph
tbe
anaplasma
phagocytophilum
ehrlichia
chaffeensi
borrelia
burgdorferi
sl
none
pathogen
detect
patient
continu
variabl
report
median
interquartil
rang
iqr
h
test
u
test
wilcoxon
test
test
use
evalu
differ
among
group
surviv
ef
calcul
date
complet
remiss
first
event
ie
relaps
death
caus
surviv
curv
calcul
use
method
surviv
comparison
made
use
mantel
test
statist
analys
perform
use
spss
version
spss
inc
chicago
il
p
valu
consid
statist
signific
studi
includ
adult
patient
shlh
patient
identifi
viraemia
among
virus
measur
ebv
common
viru
seen
patient
among
patient
viral
shlh
previou
ebv
infect
confirm
antibodi
test
accordingli
analys
ebv
antibodi
patient
posit
ebv
viraemia
data
show
antibodi
posit
patient
ebv
viraemia
indic
patient
previou
ebv
infect
next
common
viru
five
case
two
case
infect
ebv
two
case
mpv
one
case
thirti
patient
shlh
find
viraemia
divid
patient
two
group
neg
viraemia
posit
viraemia
case
posit
viraemia
server
case
case
neg
viraemia
eight
server
case
sever
case
fell
viral
group
group
incid
vs
respect
among
sever
shlh
patient
viraemia
eight
induc
ebv
two
case
induc
ebv
among
case
shlh
primari
etiolog
lymphoma
six
case
pulmonari
infect
nine
case
immun
thrombocytopenia
four
case
alcohol
hepat
three
case
four
case
shlh
induc
still
diseas
enceph
lymphnod
diabet
one
case
four
case
induc
myelodysplasia
myeloid
prolifer
disord
multipl
myeloma
acut
leukemia
one
case
studi
patient
experienc
variou
clinic
present
high
fever
present
case
especi
sever
one
mean
temperatur
rang
shlh
patient
bodi
temperatur
significantli
higher
sever
case
mild
case
sever
patient
ill
rapidli
fatal
within
day
week
major
patient
transfer
intens
care
unit
treatment
mortal
rate
viral
patient
shlh
patient
order
compar
differ
viral
case
shlh
well
sever
shlh
case
patient
divid
four
group
sever
fatal
case
posit
neg
viraemia
case
posit
neg
viraemia
accordingli
demograph
clinic
characterist
lab
data
analyz
differ
observ
age
among
four
group
rang
year
male
patient
common
femal
patient
account
laboratori
biomark
patient
four
group
present
tabl
high
ferritin
level
ngml
observ
patient
shlh
sever
could
jump
ngml
upper
limit
measur
sever
sever
shlh
case
sever
patient
ferritin
level
higher
posit
neg
viraemia
group
though
differ
reach
statist
signific
p
neg
viraemia
group
ferritin
level
sever
case
significantli
higher
mild
case
p
level
ldh
significantli
higher
posit
neg
viraemia
group
p
ldh
level
signific
higher
sever
case
case
viral
shlh
group
p
liver
enzym
especi
ast
alt
significantli
higher
patient
sever
shlh
shlh
regardless
etiolog
p
ast
alt
patient
viraemia
significantli
higher
group
p
furthermor
case
shlh
viral
ast
alt
level
remain
lower
level
data
reveal
ast
alt
biomark
reflect
diseas
sever
statu
shlh
crp
level
significantli
higher
sever
shlh
case
case
viral
shlh
p
howev
amplitud
variat
crp
significantli
higher
ferritin
indic
ferritin
may
sensit
marker
crp
reflect
infecti
statu
shlh
data
reveal
serum
ferritin
ldh
ast
alt
valuabl
biomark
reflect
diseas
sever
shlh
serum
fib
level
within
normal
limit
shlh
wherea
fib
lower
sever
shlh
patient
viraemia
p
shlh
differ
observ
fib
level
sever
group
cholesterol
level
normal
patient
triglycerid
significantli
higher
sever
shlh
group
shlh
group
subgroup
differ
statist
signific
p
peripher
blood
bm
sampl
obtain
patient
time
diseas
onset
pancytopenia
found
patient
white
blood
cell
wbc
platelet
reduc
significantli
patient
nadir
wbc
platelet
found
sever
viral
shlh
hemophagocytosi
found
bm
patient
enlarg
histiocyt
engulf
red
blood
cell
granulocyt
lymphocyt
engulf
plasma
cell
could
observ
occasion
hemophagocytosi
consist
mainli
erythrophagocytosi
fig
b
cytolog
find
reveal
hypercellular
bm
evid
malign
except
patient
acut
leukemia
myelodysplasia
myeloid
prolifer
disord
lymphoma
normal
erythropoiesi
granulopoiesi
matur
megakaryopoiesi
found
patient
patient
posit
viraemia
increas
lymphocyt
observ
blood
bm
laboratori
data
shlh
patient
viraemia
shown
tabl
ii
level
ferritin
ldh
ast
alt
ggt
group
significantli
higher
group
p
immunoglobulin
ig
g
igm
iga
level
group
significantli
lower
shlh
group
p
lower
level
fib
wbc
well
higher
level
crp
triglycerid
found
shlh
group
group
differ
reach
statist
signific
p
posit
correl
found
ebv
dna
load
age
r
p
ast
r
p
alp
r
p
fig
point
confirm
find
mean
ebv
load
copiesml
server
shlh
patient
ebv
viraemia
mean
ebv
load
copiesml
shlh
patient
ebv
viraemia
indic
ebv
load
associ
diseas
sever
statu
result
indic
ebv
dna
load
influenc
diseas
develop
shlh
patient
ebv
viraemia
patient
even
shlh
receiv
specif
antivir
treatment
viral
infect
taken
consider
diagnosi
instead
patient
treat
convent
protocol
primari
diseas
symptomat
treatment
surviv
inform
collect
march
median
time
initi
diseas
onset
death
vari
accord
sever
case
nine
shlh
patient
viraemia
seven
patient
without
viraemia
die
surviv
time
fatal
case
rang
day
viraemia
case
five
patient
die
failur
two
patient
die
respiratori
failur
one
patient
die
dissemin
intravascular
coagul
dic
one
patient
die
sever
pneumonia
mortal
rate
higher
patient
ebv
viraemia
viraemia
especi
high
viral
load
copiesml
tabl
iii
case
two
patient
die
failur
two
patient
die
primari
diseas
lymphoma
patient
die
dic
two
patient
die
sever
infect
patient
surviv
surviv
curv
reveal
surviv
time
significantli
shorter
patient
shlh
shlh
similarli
ef
significantli
shorter
patient
sever
shlh
shlh
viral
group
fig
data
demonstr
patient
shlh
poorer
outcom
shlh
shlh
patient
viraemia
poorer
surviv
rate
patient
without
viraemia
shlh
diseas
patient
may
deterior
rapidli
diseas
onset
die
dysfunct
complic
children
outcom
shlh
report
includ
overal
respons
rate
therapi
includ
corticosteroid
etoposid
cyclosporin
contrast
adult
patient
infecti
shlh
die
within
day
month
sharp
et
al
factor
affect
diseas
prognosi
remain
incomplet
understood
diagnosi
treatment
shlh
adult
challeng
major
report
data
pediatr
patient
network
adult
shlh
also
shlh
occur
mani
diseas
entiti
janka
lehmberg
otrock
ebi
present
incid
shlh
increas
howev
systemat
studi
conduct
incid
clinic
featur
subtyp
shlh
rouphael
talati
et
al
ebv
belong
group
b
lymphotrop
human
virus
ebv
infect
global
popul
preval
vari
sociodemograph
region
svahn
et
al
ebv
also
one
frequent
pathogen
found
shlh
fox
et
al
report
herp
case
shlh
caus
infect
ebv
caus
cmv
infect
dean
selmi
et
al
although
predomin
caus
shlh
differ
countri
popul
specif
genet
background
differ
suspect
trigger
agent
major
shlh
case
asian
countri
caus
ebv
infect
imashuku
phenomenon
possibl
due
pathogen
ebv
strain
present
region
rouphael
talati
et
al
janka
lehmberg
studi
consist
find
incid
shlh
higher
shlh
case
also
ebv
main
viru
found
fatal
case
moreov
mean
ebv
load
significantli
higher
server
viral
shlh
patient
viral
shlh
patient
indic
ebv
load
could
influenc
diseas
develop
shlh
patient
ebv
infect
ebv
induc
shlh
confer
worst
prognosi
rouphael
talati
et
al
ebv
infect
via
oropharyng
rout
transmit
primarili
saliva
primari
ebv
infect
mostli
asymptomat
follow
primari
infect
ebv
dna
detect
blood
mainli
individu
rapidli
clear
week
bauer
et
al
zoufali
et
al
ebv
establish
lifelong
latenc
low
copi
number
copi
among
cell
memori
compart
heslop
incid
potenti
complic
depend
ebv
viral
load
studi
ebv
viral
titer
significantli
higher
sever
shlh
patient
patient
moreov
patient
wors
prognosi
higher
ebv
copi
good
prognosi
vs
clinic
ebv
dnaemia
infecti
complic
follow
hematopoiet
stem
cell
solid
organ
transplant
hiv
infect
signific
proport
patient
ebv
dnaemia
ocheni
et
al
van
esser
et
al
zoufali
stellbrink
et
al
scarc
data
ebv
viraemia
exist
patient
shlh
ebv
antibodi
detect
patient
ebv
reactiv
suspect
patient
ebv
reactiv
like
due
immunosuppress
persist
ebv
infect
bamoulid
et
al
studi
diagnos
patient
treat
use
convent
therapi
viral
infect
seldom
consid
etiolog
shlh
treatment
viral
infect
lack
thu
exclud
whether
high
mortal
rate
among
patient
shlh
result
ineffect
therapi
though
effect
treatment
viral
infect
conclud
prognosi
sever
case
shlh
better
case
shlh
compar
ebv
viral
shlh
includ
mpv
better
prognos
molecular
mechan
underli
viru
shlh
unclear
driven
condit
trigger
viral
replic
postul
specul
hypercytokinemia
impair
normal
function
cytotox
nk
cell
shlh
hemophagocytosi
cytokin
overproduct
may
result
cellular
damag
dysfunct
et
al
muralitharan
et
al
cytokin
storm
shlh
pronounc
diseas
caus
hemophagocytosi
organ
dysfunct
might
explain
major
fatal
case
found
shlh
shlh
manifest
overwhelm
hypercytokinemia
treatment
infect
might
suffici
han
et
al
shlh
clinic
mimic
infect
obscur
coexist
rouphael
talati
et
al
thu
major
import
physician
awar
clinic
pictur
shlh
sepsi
mod
share
common
featur
syndrom
reliabl
discrimin
use
diagnost
criteria
devis
shlh
alon
therefor
diagnosi
shlh
must
reli
clinic
laboratori
histopatholog
find
henter
horn
et
al
phagocytosi
blood
cell
hallmark
shlh
goel
et
al
inflamm
macrophag
may
engulf
erythrocyt
leukocyt
platelet
precursor
cell
enact
uniqu
evolv
aspect
macrophag
biolog
risma
jordan
studi
hemophagocytosi
found
bm
smear
patient
indic
bm
hemophagocytosi
high
sensit
diagnos
shlh
signific
overlap
clinic
laboratori
find
shlh
malign
diseas
particularli
lymphoma
tumor
metastasi
sepsi
multipl
organ
dysfunct
syndrom
mod
make
difficult
differenti
patient
castillo
carcillo
circumst
hemophagocytosi
would
help
differenti
diagnos
patient
especi
fulfil
criteria
shlh
overlook
among
variou
biomark
avail
diagnos
shlh
presenc
hemophagocytosi
practition
continu
reli
time
differenti
diagnos
patient
gupta
et
al
hemophagocytosi
trigger
specif
interferon
gamma
direct
action
macrophag
lead
develop
sever
consumpt
anemia
cytopenia
zoller
et
al
inde
unexplain
acut
cytopenia
commonli
observ
associ
wors
outcom
critic
ill
patient
risma
jordan
although
hemophagocytosi
high
sensit
differenti
diagnosi
observ
patient
prognosi
variou
even
hemophagocytosi
observ
bm
gupta
et
al
serum
ferritin
biomark
final
common
pathway
system
inflammatori
respons
hyperferritinemia
frequent
use
marker
shlh
sever
studi
higher
level
ferritin
ldh
ast
alt
found
sever
shlh
group
compar
shlh
group
indic
ferritin
ldh
ast
alt
sensit
biomark
reflect
diseas
sever
shlh
studi
shlh
patient
ebv
viraemia
inadequ
diseas
control
die
within
day
week
diseas
onset
wherea
signific
fraction
shlh
patient
lower
viru
load
without
viraemia
respond
adequ
convent
therapi
major
experienc
complet
respons
although
possibl
elucid
mechan
data
reveal
patient
high
ebv
dna
titer
wors
prognos
